Mounjaro Weight- loss Drug

UPDATE: NHS Prescribing of Weight Loss Drugs as of 23rd June 2025.

We are receiving a significant number of enquiries about the availability of the Mounjaro weight-loss drug which has been approved by NHS England for eligible patients. The BBC has announced that GPs will be able to prescribe it.

Currently Townhead Surgery GPs cannot prescribe Mounjaro for weight loss.

Although NHS England has approved the drug, all GPs are waiting for information (from our local ICB: Integrated Care Board) about how the drug will be provided to eligible patients, when, and for how long. We are also awaiting guidance about how the drug should be used by patients along with other services to support weight management, such as diet and exercise.

NHS England has set the criteria for eligibility for the drug; this is a national policy which all NHS prescribers, such as GPs and pharmacists, are required to abide by. The criteria for weight management cannot be changed by prescribers.

Current guidance is that anyone with a BMI of 40 or higher, and with four or more of the qualifying comorbidities (hypertension, high cholesterol, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes) will be eligible for assessment to identify their suitability for Mounjaro. Anyone not meeting these criteria will not be eligible for assessment in the first year of the drug being available.